Skip to main content
Independent and nonpartisan. SaveYourState is a civic information resource. It is not a government website and is not affiliated with any government agency, party, or campaign.

Maryland · 2025 Regular Session · Bill

SB 393: Health Insurance - Prescription Drug Formularies and Coverage for Generic Drugs and Biosimilars

In committee Official data

  1. Introduced
  2. In committee
  3. Passed one chamber
  4. Passed both chambers
  5. Enacted

Last official action: ·Record last updated:

Plain-language summary

SB 393 is a bill introduced in the Maryland Senate on January 17, 2025. According to its official title, it concerns: Health Insurance - Prescription Drug Formularies and Coverage for Generic Drugs and Biosimilars. Primary sponsor: Clarence Lam (Democratic). Most recent recorded action (February 10, 2025): Withdrawn by Sponsor.

Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written

Sponsors

Sponsors by party (alphabetical): Democratic 1

NameRolePartyChamberDistrict
Clarence LamPrimary sponsorDemocraticSenate12

“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.

Recent official actions

  1. Withdrawn by Sponsor
  2. Hearing canceled
  3. Hearing 2/05 at 2:00 p.m.
  4. First Reading Finance

Sources

  1. Open States / Plural (data from the official legislature website)
  2. Official legislature source